CIAM
AEMD icon

Caitong International Asset Management’s Aethlon Medical AEMD Stock Holding History

Caitong International Asset Management’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18 Buy
+8
New +$18 ﹤0.01% 2085

Other funds holding AEMD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Caitong International Asset Management's AEMD Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Aethlon Medical (AEMD) in Q1 2026: 8 shares worth $18. The stake represents ﹤0.01% of the portfolio and ranks #2085 among its holdings.

12 funds tracked by Wall St. Rank hold AEMD as of Q1 2026.

  • Caitong International Asset Management held 8 shares of Aethlon Medical worth $18 as of Q1 2026.
  • Aethlon Medical was a new Caitong International Asset Management position in Q1 2026.
  • Aethlon Medical made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2085 holding.
  • 12 funds tracked by Wall St. Rank held Aethlon Medical as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.